Hepion Pharmaceuticals, Inc. (HEPA) AI Dilution Summary
Updated Nov 1, 2026
Estimated cash was $1,447,442 as of 2026-10-06, rolled forward from $1,628,625 at 2026-06-30 against estimated monthly burn of $464,652. The company funds itself through private placements, most recently a $500,000 secured convertible note to Gravitas Capital LP closed 2026-09-03, and separately agreed to issue 25,000,000 common shares on 2026-10-06, raising no cash.